Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by GerritEtmans

T.ELVA

RE: Fire at APS site

Most astonishing in this situation: the share price has shown no signs of...

January 7, 2013

FTPLF

I call BS on: I was in jail with Azorean

Azorean is just a small investor who was once the most enthusiastic...

December 31, 2012

T.ELVA

RE: Electrovaya Upgraded To 'Sector Outperformer'

You quoted: The analyst widened 2013 loss per share estimate to $0.08 from $0...

December 17, 2012

T.ELVA

RE: Electrovaya made NO real profit.

I can tell: you only read the rah-rah press release. Now, I admit, they made...

December 13, 2012

T.ELVA

RE: Yoo Hoo - Mr. Hart?!??

Paul Hart cannot hear you.  He is in Norway, firing everyone at Miljobil...

October 27, 2012

T.ELVA

RE: "Clueless"

I am not an admirer of EFL's management, but I would never use a more...

August 6, 2012

T.ELVA

RE: kinggeorge - it's going DOWN!!

Stop rubbing it in; instead, write something helpful.  For example, that...

July 27, 2012

FTPLF

RE: RE: RE: Marry a Stock: More 52 week lows: Thur

Invective is the last resort of the small mind.

July 20, 2012

T.ELVA

RE: SlimJimTheChin1

Hey Vara: I didn't know you had a passport . . .

July 16, 2012

T.ELVA

For what it's worth (not much IMHO)

http://www.moneyweek.com/investments/commodities/energy/how-to-profit-global...

July 2, 2012

FTPLF

RE: RE: Added some

I am happy for you to have added 1028 shares at an aggregate $18.  I...

June 11, 2012

T.ELVA

RE: RE: RE: Electrovaya Q2 results are great!

Vara: you should read the Income Statement and the Balance Sheet, not the...

May 16, 2012

T.ELVA

RE: Electrovaya Q2 results are great!

Vara:  Please explain where you see greatness.  Specifically...

May 14, 2012

T.ELVA

RE: 28, to 53 FEET - not inches.

Not that you think that EFL shrank their packs by a factor of 12 ;-) Those...

May 3, 2012

T.ELVA

RE: 28, to 53 inches.

too bad . . .  Well, what he meant: EFL produces cells without using the...

May 3, 2012

T.ELVA

All 25 Minivans have been

delivered

April 19, 2012

T.ELVA

RE: A123 Systems tanking is good news for EFL?

I already heard that the new Fisker model Nina (Atlantic) will be using...

April 7, 2012

T.ELVA

RE: RE: Shareholders' Meeting

Between your informative reply, the share price development since the annual...

April 3, 2012

T.ELVA

Shareholders' Meeting

I couldn't go to the meeting this year, as I did not own shares on the...

March 31, 2012

T.ELVA

RE: RE: RE: RE: RE: I like this Fact

Vestmed: I appreciate the civilized response, rather than calling me an idiot...

March 22, 2012

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

NurExone Biologic Inc.

NurExone Biologic Inc. V.NRX

NurExone Biologic Inc. is a biopharmaceutical company. The Company is developing and commercializing an exosome therapy ... view more »